Surmodics Reports First Quarter of Fiscal Year 2024 Financial Results; Updates Fiscal Year 2024 Financial GuidanceBusiness Wire • 02/01/24
Surmodics Announces Successful Early Clinical Use of Pounce™ LP (Low Profile) Thrombectomy System, Designed to Address a Critical, Unmet Need by Facilitating Removal of Thrombi and Emboli Below the KneeBusiness Wire • 01/22/24
Surmodics to Report First Quarter of Fiscal 2024 Financial Results on February 1Business Wire • 01/16/24
SurModics (SRDX) Soars 6.2%: Is Further Upside Left in the Stock?Zacks Investment Research • 12/14/23
Surmodics Announces 24-Month Data from the SWING Trial Presented at VEITHsymposiumBusiness Wire • 11/16/23
Surmodics Announces TRANSCEND Trial 36-Month Data Presented at 50th Annual VEITH SymposiumBusiness Wire • 11/16/23
Surmodics to Participate in the Piper Sandler Healthcare Conference on November 28Business Wire • 11/14/23
2 Highly Ranked Medical Stocks to Consider After Healthy Quarterly ResultsZacks Investment Research • 11/10/23
SurModics (SRDX) Reports Q4 Earnings: What Key Metrics Have to SayZacks Investment Research • 11/08/23
Surmodics Reports Fourth Quarter and Fiscal Year 2023 Financial Results; Introduces Fiscal Year 2024 Financial GuidanceBusiness Wire • 11/08/23
Surmodics Announces SWING Trial 24-Month Data to be Presented at VEITH Symposium on November 15Business Wire • 11/07/23
Surmodics Announces TRANSCEND Trial 36-Month Data to be Presented at 50th Annual VEITH SymposiumBusiness Wire • 11/07/23
Surmodics Announces Launch of Preside™ Medical Device Coating Technology, Providing Industry-Leading Lubricity and Durability to a Broader Range of Complex Device ApplicationsBusiness Wire • 10/31/23
Surmodics to Report Fourth Quarter and Fiscal 2023 Financial Results on November 8Business Wire • 10/10/23